The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis.

N. D. Stefano;M. Filippi;C. Confavreux;P. Vermersch;M. Simu;C. Sindic;R. Hupperts;O. Bajenaru;G. Edan;L. Grimaldi;I. Marginean;R. Medaer;G. Orefice;I. Pascu;J. Pelletier;E. Sanders;E. Scarpini;MANCARDI, GIOVANNI LUIGI

2009-01-01